PLA2G3 Antikörper (AA 263-502)
Kurzübersicht für PLA2G3 Antikörper (AA 263-502) (ABIN2800419)
Target
Alle PLA2G3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 263-502
-
Verwendungszweck
- PLA2G3 antibody [C1C3], 1 mg/ml
-
Immunogen
- Recombinant fragment corresponding to a region within amino acids 263-502 of PLA2G3
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Tested Western blot
Application Notes
Suggested starting dilutions are as follows: WB: 1:500-1:3000. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user.Sample (30 μg of whole cell lysate) A: Molt-4 7.5 % SDS PAGE 107-10938 diluted at 1:1000 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 0.1M Tris, 0.1M Glycine, 10 % Glycerol ( pH 7). 0.01 % Thimerosal was added as a preservative.
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- PLA2G3 (Phospholipase A2, Group III (PLA2G3))
-
Andere Bezeichnung
- PLA2G3
-
Molekulargewicht
- 57 kDa
-
Gen-ID
- 50487
Target
-